speb/financial-data huggingface dataset:
CHYM cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 693050000.00
CHYM cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -78189000.00
CHYM income_statement (annual, 2025-12-31) — Net Income: -1009936000.00
CHYM income_statement (quarterly, 2025-12-31) — Net Income: -44777000.00
CHYM income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -1009936000.00
CHYM income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -44777000.00
CHYM income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -1009936000.00
CHYM income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -44777000.00
CHYM income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1009936000.00
CHYM income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -44777000.00
CHYM income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1009936000.00
CHYM income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -44777000.00
CHYM cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -1009936000.00
CHYM cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -44777000.00
CHYM income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -1009936000.00
CHYM income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -44777000.00
CHYM cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -213746000.00
CHYM cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 47823000.00
CHYM cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -350540000.00
CHYM cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1334000.00
CHYM cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -47222000.00
CHYM cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 21958000.00
CHYM balance_sheet (annual, 2025-12-31) — Net PPE: 177749000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Net PPE: 177749000.00
CHYM cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -19887000.00
CHYM cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -14199000.00
CHYM balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1401706000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1401706000.00
CHYM income_statement (annual, 2025-12-31) — Normalized EBITDA: -1009979000.00
CHYM income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -45951000.00
CHYM income_statement (annual, 2025-12-31) — Normalized Income: -1009936000.00
CHYM income_statement (quarterly, 2025-12-31) — Normalized Income: -44777000.00
CHYM cash_flow (annual, 2025-12-31) — Operating Cash Flow: 52780000.00
CHYM cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 32553000.00
CHYM income_statement (annual, 2025-12-31) — Operating Income: -1039979000.00
CHYM income_statement (quarterly, 2025-12-31) — Operating Income: -53768000.00
CHYM income_statement (annual, 2025-12-31) — Operating Revenue: 2186770000.00
CHYM income_statement (quarterly, 2025-12-31) — Operating Revenue: 596358000.00
CHYM balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 379933372.00
CHYM balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 379933372.00
CHYM balance_sheet (annual, 2025-12-31) — Other Current Assets: 106753000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 106753000.00
CHYM balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 193069000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 193069000.00
CHYM balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 172000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 172000.00
CHYM income_statement (annual, 2025-12-31) — Other Gand A: 512113000.00
CHYM income_statement (quarterly, 2025-12-31) — Other Gand A: 108698000.00
CHYM income_statement (annual, 2025-12-31) — Other Income Expense: 30874000.00
CHYM income_statement (quarterly, 2025-12-31) — Other Income Expense: 9037000.00
CHYM cash_flow (annual, 2025-12-31) — Other Non Cash Items: 54910000.00
CHYM cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -3270000.00
CHYM balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 30846000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 30846000.00
CHYM balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 51691000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 51691000.00
CHYM income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 30874000.00
CHYM income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 9037000.00
CHYM income_statement (annual, 2025-12-31) — Other Operating Expenses: 865301000.00
CHYM income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 195492000.00
CHYM balance_sheet (annual, 2025-12-31) — Other Properties: 83429000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Other Properties: 83429000.00
CHYM balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 587828000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 587828000.00
CHYM balance_sheet (annual, 2025-12-31) — Payables: 38680000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Payables: 38680000.00
CHYM balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 130614000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 130614000.00
CHYM balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 52860000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 52860000.00
CHYM balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CHYM balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CHYM income_statement (annual, 2025-12-31) — Pretax Income: -1009105000.00
CHYM income_statement (quarterly, 2025-12-31) — Pretax Income: -44731000.00
CHYM cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 25158000.00
CHYM cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 14233000.00
CHYM balance_sheet (annual, 2025-12-31) — Properties: 0.00
CHYM balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CHYM cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 141225000.00
CHYM cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 30911000.00
CHYM cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
CHYM cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
CHYM cash_flow (annual, 2025-12-31) — Purchase Of Investment: -734960000.00
CHYM cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -69677000.00
CHYM cash_flow (annual, 2025-12-31) — Purchase Of PPE: -19887000.00
CHYM cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -14199000.00
CHYM balance_sheet (annual, 2025-12-31) — Receivables: 329465000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Receivables: 329465000.00
CHYM income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 249026000.00
CHYM income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 62575000.00
CHYM income_statement (annual, 2025-12-31) — Reconciled Depreciation: 30000000.00
CHYM income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7817000.00
CHYM cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -77538000.00
CHYM cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -77538000.00
CHYM income_statement (annual, 2025-12-31) — Research And Development: 934925000.00
CHYM income_statement (quarterly, 2025-12-31) — Research And Development: 111347000.00
CHYM balance_sheet (annual, 2025-12-31) — Restricted Cash: 265712000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 265712000.00
CHYM balance_sheet (annual, 2025-12-31) — Retained Earnings: -3374104000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -3374104000.00
CHYM cash_flow (annual, 2025-12-31) — Sale Of Investment: 521214000.00
CHYM cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 117500000.00
CHYM income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 635384000.00
CHYM income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 164197000.00
CHYM income_statement (annual, 2025-12-31) — Selling General And Administration: 1147497000.00
CHYM income_statement (quarterly, 2025-12-31) — Selling General And Administration: 272895000.00
CHYM balance_sheet (annual, 2025-12-31) — Share Issued: 379933372.00
CHYM balance_sheet (quarterly, 2025-12-31) — Share Issued: 379933372.00
CHYM cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1070898000.00
CHYM cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 67300000.00
CHYM balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1401706000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1401706000.00
CHYM balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1401706000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1401706000.00
CHYM income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CHYM income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CHYM income_statement (annual, 2025-12-31) — Tax Provision: 831000.00
CHYM income_statement (quarterly, 2025-12-31) — Tax Provision: 46000.00
CHYM income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CHYM income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CHYM balance_sheet (annual, 2025-12-31) — Total Assets: 1964605000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Total Assets: 1964605000.00
CHYM balance_sheet (annual, 2025-12-31) — Total Capitalization: 1401706000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1401706000.00
CHYM balance_sheet (annual, 2025-12-31) — Total Debt: 134665000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Total Debt: 134665000.00
CHYM balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1401706000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1401706000.00
CHYM income_statement (annual, 2025-12-31) — Total Expenses: 3226749000.00
CHYM income_statement (quarterly, 2025-12-31) — Total Expenses: 650126000.00
CHYM balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 562899000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 562899000.00
CHYM balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 208595000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 208595000.00
CHYM balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 174975000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 174975000.00
CHYM income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -1039979000.00
CHYM income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -53768000.00
CHYM balance_sheet (annual, 2025-12-31) — Working Capital: 1368086000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Working Capital: 1368086000.00
CHYM income_statement (quarterly, 2026-03-31) — +Operating Expense: 534150000.00
CHYM income_statement (quarterly, 2026-03-31) — +Total Revenue: 647387000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 37920000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 294338000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -81073000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4763006000.00
CHYM cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -162000.00
CHYM income_statement (quarterly, 2026-03-31) — Basic Average Shares: 381636920.00
CHYM income_statement (quarterly, 2026-03-31) — Basic EPS: 0.14
CHYM cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 480760000.00
CHYM cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -7452000.00
CHYM cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -831000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 132736000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Capital Stock: 31000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 607677000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1011282000.00
CHYM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -73357000.00
CHYM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 127305000.00
CHYM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 87479000.00
CHYM cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -760000.00
CHYM cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -47399000.00
CHYM cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -1623000.00
CHYM cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 19727000.00
CHYM cash_flow (quarterly, 2026-03-31) — Change In Payable: -760000.00
CHYM cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -48159000.00
CHYM cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 19972000.00
CHYM cash_flow (quarterly, 2026-03-31) — Change In Receivables: -37679000.00
CHYM cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -47762000.00
CHYM cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -37679000.00
CHYM cash_flow (quarterly, 2026-03-31) — Changes In Cash: 141427000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Common Stock: 31000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1441442000.00
CHYM cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -85740000.00
CHYM income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 67074000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 108515000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Current Assets: 1744261000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 12122000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 12122000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 344099000.00
CHYM cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 7665000.00
CHYM income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 4168000.00
CHYM cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 7665000.00
CHYM income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 4168000.00
CHYM income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 400476567.00
CHYM income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.13
CHYM income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 53456000.00
CHYM income_statement (quarterly, 2026-03-31) — EBIT: 46163000.00
CHYM income_statement (quarterly, 2026-03-31) — EBITDA: 53828000.00
CHYM cash_flow (quarterly, 2026-03-31) — End Cash Position: 622187000.00
CHYM cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -73357000.00
CHYM cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 80027000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -947000.00
CHYM income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 70467000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Gross PPE: 256787000.00
CHYM income_statement (quarterly, 2026-03-31) — Gross Profit: 580313000.00
CHYM cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 40000.00
CHYM cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 280000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1441442000.00
CHYM cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 127305000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Leases: 83769000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 105815000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 120614000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 120614000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 91940000.00
CHYM cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -85740000.00
CHYM income_statement (quarterly, 2026-03-31) — Net Income: 53456000.00
CHYM income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 53456000.00
CHYM income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 53456000.00
CHYM income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 53456000.00
CHYM income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 53456000.00
CHYM cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 53456000.00
CHYM income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 53456000.00
CHYM cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 182300000.00
CHYM cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1540000.00
CHYM cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -47543000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Net PPE: 175714000.00
CHYM cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -6621000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1441442000.00
CHYM income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 53828000.00
CHYM income_statement (quarterly, 2026-03-31) — Normalized Income: 53456000.00
CHYM cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 87479000.00
CHYM income_statement (quarterly, 2026-03-31) — Operating Income: 46163000.00
CHYM income_statement (quarterly, 2026-03-31) — Operating Revenue: 647387000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 382604119.00
CHYM balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 86839000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 173814000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -947000.00
CHYM income_statement (quarterly, 2026-03-31) — Other Gand A: 70467000.00
CHYM income_statement (quarterly, 2026-03-31) — Other Income Expense: 7748000.00
CHYM cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -23231000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 30408000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 44228000.00
CHYM income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 7748000.00
CHYM income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 184304000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Other Properties: 81078000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 403605000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Payables: 37920000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 146435000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 11728000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CHYM income_statement (quarterly, 2026-03-31) — Pretax Income: 53911000.00
CHYM cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 13923000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CHYM cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 36861000.00
CHYM cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
CHYM cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -6621000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Receivables: 400153000.00
CHYM income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 63577000.00
CHYM income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 7665000.00
CHYM cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -85740000.00
CHYM income_statement (quarterly, 2026-03-31) — Research And Development: 109780000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 245987000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -3320648000.00
CHYM cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 182300000.00
CHYM income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 165431000.00
CHYM income_statement (quarterly, 2026-03-31) — Selling General And Administration: 235898000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Share Issued: 382604119.00
CHYM cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 60652000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1441442000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1441442000.00
CHYM income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CHYM income_statement (quarterly, 2026-03-31) — Tax Provision: 455000.00
CHYM income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.01
CHYM balance_sheet (quarterly, 2026-03-31) — Total Assets: 1950383000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1441442000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Total Debt: 132736000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1441442000.00
CHYM income_statement (quarterly, 2026-03-31) — Total Expenses: 601224000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 508941000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 206122000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 164842000.00
CHYM income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 46163000.00
CHYM balance_sheet (quarterly, 2026-03-31) — Working Capital: 1400162000.00
CI income_statement (annual, 2021-12-31) — +Operating Expense: 177048000000.00
CI income_statement (annual, 2021-12-31) — Amortization Of Intangibles Income Statement: 5994000000.00
CI income_statement (annual, 2021-12-31) — Cost Of Revenue: 1360062000000.00
CI income_statement (annual, 2021-12-31) — Depreciation Amortization Depletion Income Statement: 35964000000.00
CI income_statement (annual, 2021-12-31) — EBITDA: 59958000000.00
CI income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 0.00
CI income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 15723000000.00
CI income_statement (annual, 2021-12-31) — Gross Profit: 192618000000.00
CI cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 2240000000.00
CI balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 1354000000.00
CI income_statement (annual, 2021-12-31) — Normalized EBITDA: 45504000000.00
CI income_statement (annual, 2021-12-31) — Operating Income: 15570000000.00
CI balance_sheet (annual, 2021-12-31) — Other Current Liabilities: -126196000000.00
CI balance_sheet (annual, 2021-12-31) — Other Equity Interest: -88194000000.00
CI income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 792000000.00
CI balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 54000000.00
CI income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 1393103000000.00
CI income_statement (annual, 2021-12-31) — Total Operating Income As Reported: 23823000000.00
CI income_statement (annual, 2021-12-31) — Total Other Finance Cost: 4832000000.00
CI income_statement (annual, 2022-12-31) — +Operating Expense: 15050000000.00
CI income_statement (annual, 2022-12-31) — +Total Revenue: 179363000000.00
CI balance_sheet (annual, 2022-12-31) — Accounts Payable: 30254000000.00
CI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 17218000000.00
CI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -7430000000.00
CI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 30233000000.00
CI balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -1900000000.00
CI income_statement (annual, 2022-12-31) — Amortization: 1876000000.00
CI cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 2674000000.00
CI cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 2674000000.00
CI income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 1876000000.00
CI balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
CI balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 577000000.00
CI income_statement (annual, 2022-12-31) — Basic Average Shares: 298676000.00
CI income_statement (annual, 2022-12-31) — Basic EPS: 22.33
CI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 5548000000.00
CI cash_flow (annual, 2022-12-31) — Capital Expenditure: -1295000000.00
CI balance_sheet (annual, 2022-12-31) — Capital Stock: 4000000.00
CI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 5924000000.00
CI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 6762000000.00
CI cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -1384000000.00
CI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -11240000000.00
CI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 3098000000.00
CI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 8656000000.00
CI cash_flow (annual, 2022-12-31) — Change In Account Payable: 1734000000.00
CI cash_flow (annual, 2022-12-31) — Change In Inventory: -1055000000.00
CI cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -1055000000.00
CI cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -336000000.00
CI cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 393000000.00
CI cash_flow (annual, 2022-12-31) — Change In Payable: 3494000000.00
CI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 3494000000.00
CI cash_flow (annual, 2022-12-31) — Change In Receivables: -2237000000.00
CI cash_flow (annual, 2022-12-31) — Change In Working Capital: 259000000.00
CI cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -2237000000.00
CI cash_flow (annual, 2022-12-31) — Changes In Cash: 514000000.00
CI balance_sheet (annual, 2022-12-31) — Commercial Paper: 0.00
CI balance_sheet (annual, 2022-12-31) — Common Stock: 4000000.00
CI cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -1384000000.00
CI balance_sheet (annual, 2022-12-31) — Common Stock Equity: 44675000000.00
CI cash_flow (annual, 2022-12-31) — Common Stock Issuance: 389000000.00
CI cash_flow (annual, 2022-12-31) — Common Stock Payments: -7607000000.00
CI income_statement (annual, 2022-12-31) — Cost Of Revenue: 157018000000.00
CI balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 7978000000.00
CI balance_sheet (annual, 2022-12-31) — Current Assets: 30122000000.00
CI balance_sheet (annual, 2022-12-31) — Current Debt: 2993000000.00
CI balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2993000000.00
CI balance_sheet (annual, 2022-12-31) — Current Liabilities: 41225000000.00
CI balance_sheet (annual, 2022-12-31) — Current Notes Payable: 2960000000.00
CI cash_flow (annual, 2022-12-31) — Deferred Income Tax: -472000000.00
CI cash_flow (annual, 2022-12-31) — Deferred Tax: -472000000.00
CI cash_flow (annual, 2022-12-31) — Depreciation: 263000000.00
CI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 2937000000.00
CI income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 1876000000.00
CI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2937000000.00
CI income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1876000000.00
CI income_statement (annual, 2022-12-31) — Diluted Average Shares: 313065000.00
CI income_statement (annual, 2022-12-31) — Diluted EPS: 21.30
CI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 6704000000.00
CI income_statement (annual, 2022-12-31) — EBIT: 9625000000.00
CI income_statement (annual, 2022-12-31) — EBITDA: 12562000000.00
CI cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -86000000.00
CI cash_flow (annual, 2022-12-31) — End Cash Position: 5976000000.00
CI cash_flow (annual, 2022-12-31) — Financing Cash Flow: -11240000000.00
CI cash_flow (annual, 2022-12-31) — Free Cash Flow: 7361000000.00
CI cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 487000000.00
CI cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -1662000000.00
CI income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 1662000000.00
CI income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 668000000.00
CI balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -1658000000.00
CI balance_sheet (annual, 2022-12-31) — Goodwill: 45811000000.00
CI balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 78303000000.00
CI balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 19118000000.00
CI balance_sheet (annual, 2022-12-31) — Gross PPE: 11204000000.00
CI income_statement (annual, 2022-12-31) — Gross Profit: 22345000000.00
CI balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 9218000000.00
CI cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1850000000.00
CI income_statement (annual, 2022-12-31) — Interest Expense: 1228000000.00
CI income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1228000000.00
CI cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1229000000.00
CI balance_sheet (annual, 2022-12-31) — Inventory: 4777000000.00
CI balance_sheet (annual, 2022-12-31) — Invested Capital: 75768000000.00
CI cash_flow (annual, 2022-12-31) — Investing Cash Flow: 3098000000.00
CI balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 9795000000.00
CI balance_sheet (annual, 2022-12-31) — Investments And Advances: 13523000000.00
CI cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 389000000.00
CI cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CI balance_sheet (annual, 2022-12-31) — Liabilities Heldfor Sale Non Current: 0.00
CI balance_sheet (annual, 2022-12-31) — Loans Receivable: 67000000.00
CI balance_sheet (annual, 2022-12-31) — Long Term Debt: 28100000000.00
CI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 28100000000.00
CI cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CI cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -500000000.00
CI income_statement (annual, 2022-12-31) — Loss Adjustment Expense: 32184000000.00
CI balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 8948000000.00
CI balance_sheet (annual, 2022-12-31) — Minority Interest: 79000000.00
CI income_statement (annual, 2022-12-31) — Minority Interests: -78000000.00
CI cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 4835000000.00
CI cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -7218000000.00
CI balance_sheet (annual, 2022-12-31) — Net Debt: 25169000000.00
CI income_statement (annual, 2022-12-31) — Net Income: 6704000000.00
CI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 6704000000.00
CI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6782000000.00
CI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 6704000000.00
CI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 6704000000.00
CI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6782000000.00
CI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6782000000.00
CI income_statement (annual, 2022-12-31) — Net Interest Income: -1228000000.00
CI cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -209000000.00
CI cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -2559000000.00
CI cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -500000000.00
CI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1228000000.00
CI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -79000000.00
CI cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -233000000.00
CI balance_sheet (annual, 2022-12-31) — Net PPE: 3774000000.00
CI cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1295000000.00
CI income_statement (annual, 2022-12-31) — Net Policyholder Benefits And Claims: 32184000000.00
CI cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -2059000000.00
CI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -33628000000.00
CI balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 5416000000.00
CI balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 7786000000.00
CI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 7786000000.00
CI balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 2765000000.00
CI income_statement (annual, 2022-12-31) — Normalized EBITDA: 10232000000.00
CI income_statement (annual, 2022-12-31) — Normalized Income: 4821360000.00
CI cash_flow (annual, 2022-12-31) — Operating Cash Flow: 8656000000.00
CI cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1175000000.00
CI income_statement (annual, 2022-12-31) — Operating Income: 7295000000.00
CI income_statement (annual, 2022-12-31) — Operating Revenue: 168482000000.00
CI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 298676000.00
CI balance_sheet (annual, 2022-12-31) — Other Current Assets: 1298000000.00
CI balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 33000000.00
CI balance_sheet (annual, 2022-12-31) — Other Current Liabilities: -154890000000.00
CI balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -1658000000.00
CI balance_sheet (annual, 2022-12-31) — Other Equity Interest: -74470000000.00
CI income_statement (annual, 2022-12-31) — Other Income Expense: 2330000000.00
CI balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 32492000000.00
CI balance_sheet (annual, 2022-12-31) — Other Investments: 3728000000.00
CI cash_flow (annual, 2022-12-31) — Other Non Cash Items: 325000000.00
CI balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 9982000000.00
CI balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 10044000000.00
CI income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 2188000000.00
CI income_statement (annual, 2022-12-31) — Other Operating Expenses: 30124000000.00
CI balance_sheet (annual, 2022-12-31) — Other Payable: 17070000000.00
CI balance_sheet (annual, 2022-12-31) — Other Properties: 2256000000.00
CI balance_sheet (annual, 2022-12-31) — Other Receivables: 248000000.00
CI balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 838000000.00
CI income_statement (annual, 2022-12-31) — Other Special Charges: -3324000000.00
CI balance_sheet (annual, 2022-12-31) — Payables: 30254000000.00
CI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 38232000000.00
CI income_statement (annual, 2022-12-31) — Pretax Income: 8397000000.00
CI cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CI cash_flow (annual, 2022-12-31) — Purchase Of Investment: -4319000000.00
CI cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1295000000.00
CI balance_sheet (annual, 2022-12-31) — Receivables: 17285000000.00
CI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 155957000000.00
CI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2937000000.00
CI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -500000000.00
CI cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -7607000000.00
CI balance_sheet (annual, 2022-12-31) — Retained Earnings: 37940000000.00
CI cash_flow (annual, 2022-12-31) — Sale Of Business: 4835000000.00
CI cash_flow (annual, 2022-12-31) — Sale Of Investment: 4110000000.00
CI income_statement (annual, 2022-12-31) — Selling General And Administration: 13174000000.00
CI balance_sheet (annual, 2022-12-31) — Share Issued: 397819000.00
CI income_statement (annual, 2022-12-31) — Special Income Charges: 1662000000.00
CI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 44675000000.00
CI balance_sheet (annual, 2022-12-31) — Tangible Book Value: -33628000000.00
CI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 447360000.00
CI income_statement (annual, 2022-12-31) — Tax Provision: 1615000000.00
CI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.19
CI balance_sheet (annual, 2022-12-31) — Total Assets: 143885000000.00
CI balance_sheet (annual, 2022-12-31) — Total Capitalization: 72775000000.00
CI balance_sheet (annual, 2022-12-31) — Total Debt: 31093000000.00
CI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 44754000000.00
CI income_statement (annual, 2022-12-31) — Total Expenses: 172068000000.00
CI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 99131000000.00
CI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 113763000000.00
CI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 57906000000.00
CI income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 8450000000.00
CI income_statement (annual, 2022-12-31) — Total Other Finance Cost: 4912000000.00
CI income_statement (annual, 2022-12-31) — Total Unusual Items: 2330000000.00
CI income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 2330000000.00
CI balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 11976000000.00
CI balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 99143000.00
CI balance_sheet (annual, 2022-12-31) — Treasury Stock: 21844000000.00
CI balance_sheet (annual, 2022-12-31) — Working Capital: -11103000000.00
CI income_statement (annual, 2023-12-31) — +Operating Expense: 16641000000.00
CI income_statement (annual, 2023-12-31) — +Total Revenue: 194099000000.00
CI balance_sheet (annual, 2023-12-31) — Accounts Payable: 33882000000.00
CI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 17722000000.00
CI balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -8566000000.00
CI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 30669000000.00
CI balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -3700000000.00
CI income_statement (annual, 2023-12-31) — Amortization: 1819000000.00
CI cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 2768000000.00
CI cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 2768000000.00
CI income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 1819000000.00
CI balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 3068000000.00
CI balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 3331000000.00
CI income_statement (annual, 2023-12-31) — Basic Average Shares: 292504000.00
CI income_statement (annual, 2023-12-31) — Basic EPS: 17.65
CI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 5976000000.00
CI cash_flow (annual, 2023-12-31) — Capital Expenditure: -1573000000.00
CI balance_sheet (annual, 2023-12-31) — Capital Stock: 4000000.00
CI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 7822000000.00
CI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 8565000000.00
CI cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1450000000.00
CI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -4294000000.00
CI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -5174000000.00
CI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 11813000000.00
CI cash_flow (annual, 2023-12-31) — Change In Account Payable: 3481000000.00
CI cash_flow (annual, 2023-12-31) — Change In Inventory: -868000000.00
CI cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -868000000.00
CI cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 584000000.00
CI cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -539000000.00
CI cash_flow (annual, 2023-12-31) — Change In Payable: 5511000000.00
CI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 5511000000.00
CI cash_flow (annual, 2023-12-31) — Change In Receivables: -1663000000.00
CI cash_flow (annual, 2023-12-31) — Change In Working Capital: 3025000000.00
CI cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1663000000.00
CI cash_flow (annual, 2023-12-31) — Changes In Cash: 2345000000.00
CI balance_sheet (annual, 2023-12-31) — Commercial Paper: 1237000000.00
CI balance_sheet (annual, 2023-12-31) — Common Stock: 4000000.00
CI cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -1450000000.00
CI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 46223000000.00
CI cash_flow (annual, 2023-12-31) — Common Stock Issuance: 187000000.00
CI cash_flow (annual, 2023-12-31) — Common Stock Payments: -2284000000.00
CI income_statement (annual, 2023-12-31) — Cost Of Revenue: 170088000000.00
CI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 9955000000.00
CI balance_sheet (annual, 2023-12-31) — Current Assets: 37351000000.00
CI balance_sheet (annual, 2023-12-31) — Current Debt: 2775000000.00
CI balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2775000000.00
CI balance_sheet (annual, 2023-12-31) — Current Liabilities: 48716000000.00
CI balance_sheet (annual, 2023-12-31) — Current Notes Payable: 1496000000.00
CI cash_flow (annual, 2023-12-31) — Deferred Income Tax: -1659000000.00
CI cash_flow (annual, 2023-12-31) — Deferred Tax: -1659000000.00
CI cash_flow (annual, 2023-12-31) — Depreciation: 267000000.00
CI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 3035000000.00
CI income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 1819000000.00
CI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 3035000000.00
CI income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1819000000.00
CI income_statement (annual, 2023-12-31) — Diluted Average Shares: 296882000.00
CI income_statement (annual, 2023-12-31) — Diluted EPS: 17.39
CI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 5164000000.00
CI income_statement (annual, 2023-12-31) — EBIT: 6959000000.00
CI income_statement (annual, 2023-12-31) — EBITDA: 9994000000.00
CI cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 16000000.00
CI cash_flow (annual, 2023-12-31) — End Cash Position: 8337000000.00
CI cash_flow (annual, 2023-12-31) — Financing Cash Flow: -4294000000.00
CI cash_flow (annual, 2023-12-31) — Free Cash Flow: 10240000000.00
CI cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 78000000.00
CI cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 1499000000.00
CI income_statement (annual, 2023-12-31) — Gain On Sale Of Business: -1499000000.00
CI income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 1088000000.00
CI balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -1864000000.00
CI balance_sheet (annual, 2023-12-31) — Goodwill: 44259000000.00
CI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 75122000000.00
CI balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 21422000000.00
CI balance_sheet (annual, 2023-12-31) — Gross PPE: 12261000000.00
CI income_statement (annual, 2023-12-31) — Gross Profit: 24011000000.00
CI balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 9265000000.00
CI cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1471000000.00
CI income_statement (annual, 2023-12-31) — Interest Expense: 1446000000.00
CI income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1446000000.00
CI cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1330000000.00
CI balance_sheet (annual, 2023-12-31) — Inventory: 5645000000.00
CI balance_sheet (annual, 2023-12-31) — Invested Capital: 77153000000.00
CI cash_flow (annual, 2023-12-31) — Investing Cash Flow: -5174000000.00
CI balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 12596000000.00
CI balance_sheet (annual, 2023-12-31) — Investments And Advances: 15423000000.00
CI cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 187000000.00
CI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 1491000000.00
CI balance_sheet (annual, 2023-12-31) — Liabilities Heldfor Sale Non Current: 591000000.00
CI balance_sheet (annual, 2023-12-31) — Loans Receivable: 182000000.00
CI balance_sheet (annual, 2023-12-31) — Long Term Debt: 28155000000.00
CI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 28155000000.00
CI cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 1491000000.00
CI cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2967000000.00
CI income_statement (annual, 2023-12-31) — Loss Adjustment Expense: 36287000000.00
CI balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 10155000000.00
CI balance_sheet (annual, 2023-12-31) — Minority Interest: 128000000.00
CI income_statement (annual, 2023-12-31) — Minority Interests: -208000000.00
CI cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -434000000.00
CI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -2097000000.00
CI balance_sheet (annual, 2023-12-31) — Net Debt: 23108000000.00
CI income_statement (annual, 2023-12-31) — Net Income: 5164000000.00
CI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 5164000000.00
CI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 5372000000.00
CI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 5164000000.00
CI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 5164000000.00
CI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 5372000000.00
CI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 5372000000.00
CI income_statement (annual, 2023-12-31) — Net Interest Income: -1446000000.00
CI cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -2903000000.00
CI cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -278000000.00
CI cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -1476000000.00
CI income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1446000000.00
CI cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -469000000.00
CI cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -264000000.00
CI balance_sheet (annual, 2023-12-31) — Net PPE: 3695000000.00
CI cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1573000000.00
CI income_statement (annual, 2023-12-31) — Net Policyholder Benefits And Claims: 36287000000.00
CI cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 1198000000.00
CI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -28899000000.00
CI balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 4835000000.00
CI balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 7173000000.00
CI balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 7173000000.00
CI balance_sheet (annual, 2023-12-31) — Non Current Note Receivables: 2562000000.00
CI income_statement (annual, 2023-12-31) — Normalized EBITDA: 10405000000.00
CI income_statement (annual, 2023-12-31) — Normalized Income: 5564314000.00
CI cash_flow (annual, 2023-12-31) — Operating Cash Flow: 11813000000.00
CI cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1577000000.00
CI income_statement (annual, 2023-12-31) — Operating Income: 7370000000.00